Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 6:12 PM View:  | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 31% 479.61K to 629.61K | |
| 23-Jan-24 8:37 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 14,363 | -- | -- | (100%) 14.36K to 0 | |
| 03-Jan-24 6:27 PM View: | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 90% 7.55K to 14.36K | |
| 15-Nov-23 5:07 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 14-Nov-23 | Purchase | 90,980 | $0.31 | $28,185.60 | 25% 368.44K to 459.42K | |
| 15-Nov-23 5:07 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 13-Nov-23 | Private Purchase | 179,020 | $0.22 | $40,028.90 | 95% 189.42K to 368.44K | |
| 23-Jun-23 5:18 PM View: | Mirati Therapeutics, Inc. (MRTX) | 22-Jun-23 | Grant | 7,555 | -- | -- | 100% 0 to 7.55K | |
| 02-Jun-23 7:09 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 43% 132.42K to 189.42K | |
| 27-Jun-22 4:48 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 23-Jun-22 | Grant | 20,500 | -- | -- | 18% 111.92K to 132.42K | |
| 16-Jun-21 8:48 AM View: | Certara, Inc. (CERT) | 15-Jun-21 | Grant | 7,059 | -- | -- | 100% 0 to 7.06K | |
| 09-Jun-21 7:09 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 08-Jun-21 | Grant | 11,000 | -- | -- | 11% 100.82K to 111.82K | |
| 17-Jun-20 5:46 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Jun-20 | Grant | 8,000 | -- | -- | 9% 92.82K to 100.82K | |
| 01-Jul-19 5:00 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 27-Jun-19 | Grant | 4,000 | -- | -- | 5% 88.82K to 92.82K | |
| 11-Dec-18 7:38 PM View: | OvaScience, Inc. (MLND) | 07-Dec-18 | Grant | 8,249 | -- | -- | 100% 0 to 8.25K | |
| 11-Dec-18 7:38 PM View: | OvaScience, Inc. (MLND) | 07-Dec-18 | Grant | 23,684 | -- | -- | 287% 8.25K to 31.93K | |
| 07-Nov-18 7:44 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 07-Nov-18 | Market Sale | 21,374 | $36.38 | $777,586.00 | (19%) 110.19K to 88.82K | 38% |
| 19-Jun-18 4:35 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-Jun-18 | Market Sale (Planned) | 2,500 | $44.78 | $111,944.00 | (2%) 112.69K to 110.19K | 50% |
| 18-Jun-18 4:28 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 14-Jun-18 | Grant | 1,500 | -- | -- | 1% 111.19K to 112.69K | |
| 16-May-18 8:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-18 | Market Option Sale (Planned) | 273 | $46.06 | $12,574.40 | (< 1%) 111.47K to 111.19K | 51% |
| 16-May-18 8:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-18 | Option Exercise | 545 | -- | -- | < 1% 110.92K to 111.47K | |
| 20-Feb-18 8:25 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Feb-18 | Market Option Sale (Planned) | 1,183 | $46.50 | $55,009.50 | (1%) 112.1K to 110.92K | 51% |
| 20-Feb-18 8:25 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-18 | Option Exercise | 2,365 | -- | -- | 2% 109.74K to 112.1K | |
| 17-Nov-17 6:24 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-17 | Market Option Sale (Planned) | 1,184 | $14.20 | $16,812.80 | (1%) 110.92K to 109.74K | (59%) |
| 17-Nov-17 6:24 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-17 | Option Exercise | 2,366 | -- | -- | 2% 108.56K to 110.92K | |
| 17-Aug-17 5:38 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-17 | Market Option Sale (Planned) | 1,184 | $14.30 | $16,931.20 | (1%) 109.74K to 108.56K | (58%) |
| 17-Aug-17 5:38 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-17 | Option Exercise | 2,366 | -- | -- | 2% 107.37K to 109.74K | |
| 12-Jun-17 5:29 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 09-Jun-17 | Market Sale (Planned) | 1,000 | $13.15 | $13,150.00 | (< 1%) 108.37K to 107.37K | (72%) |
| 12-Jun-17 5:29 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 08-Jun-17 | Grant | 5,000 | -- | -- | 5% 103.37K to 108.37K | |
| 17-May-17 5:01 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-17 | Market Option Sale (Planned) | 1,184 | $15.25 | $18,056.00 | (1%) 104.56K to 103.37K | (48%) |
| 17-May-17 5:01 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-May-17 | Option Exercise | 2,366 | -- | -- | 2% 102.19K to 104.56K | |
| 16-Feb-17 8:12 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Feb-17 | Market Option Sale (Planned) | 1,183 | $16.10 | $19,046.30 | (1%) 103.38K to 102.19K | (40%) |
| 16-Feb-17 8:12 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Feb-17 | Option Exercise | 2,365 | -- | -- | 2% 101.01K to 103.38K | |
| 31-Jan-17 4:50 PM View: | Anaptysbio, Inc (ANAB) | 31-Jan-17 | Conversion | 64,296 | -- | -- | 100% 0 to 64.3K | |
| 05-Jan-17 4:20 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 03-Jan-17 | Grant | 2,000 | -- | -- | 2% 99.01K to 101.01K | |
| 17-Nov-16 4:51 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-16 | Market Option Sale (Planned) | 1,184 | $19.35 | $22,910.40 | (1%) 100.19K to 99.01K | (17%) |
| 17-Nov-16 4:51 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Nov-16 | Option Exercise | 2,366 | -- | -- | 2% 97.83K to 100.19K | |
| 17-Aug-16 7:45 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 15-Aug-16 | Option Exercise | 2,366 | -- | -- | 2% 95.46K to 97.83K | |
| 18-May-16 7:11 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-May-16 | Market Option Sale (Planned) | 1,184 | $15.96 | $18,896.60 | (1%) 96.65K to 95.46K | (41%) |
| 18-May-16 7:11 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-16 | Option Exercise | 2,366 | -- | -- | 3% 94.28K to 96.65K | |
| 18-Feb-16 8:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Feb-16 | Market Option Sale (Planned) | 1,183 | $16.30 | $19,282.90 | (1%) 95.46K to 94.28K | (38%) |
| 18-Feb-16 8:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Feb-16 | Option Exercise | 2,365 | -- | -- | 3% 93.1K to 95.46K | |
| 18-Nov-15 6:55 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Nov-15 | Market Option Sale (Planned) | 1,184 | $31.10 | $36,822.40 | (1%) 94.28K to 93.1K | 27% |
| 18-Nov-15 6:55 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-15 | Option Exercise | 2,366 | -- | -- | 3% 91.92K to 94.28K | |
| 24-Aug-15 7:09 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 24-Aug-15 | Market Sale (Planned) | 5,874 | $40.51 | $237,936.00 | (6%) 97.79K to 91.92K | 44% |
| 24-Aug-15 7:09 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 21-Aug-15 | Market Sale (Planned) | 5,874 | $41.71 | $245,015.00 | (6%) 103.66K to 97.79K | 46% |
| 24-Aug-15 7:09 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 20-Aug-15 | Market Sale (Planned) | 5,874 | $44.80 | $263,139.00 | (5%) 109.54K to 103.66K | 50% |
| 19-Aug-15 8:42 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 19-Aug-15 | Market Option Sale | 1,500 | $48.78 | $73,170.00 | (1%) 115.41K to 113.91K | 54% |
| 19-Aug-15 8:42 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 19-Aug-15 | Market Option Sale (Planned) | 4,375 | $47.98 | $209,912.00 | (4%) 113.91K to 109.54K | 53% |
| 19-Aug-15 8:42 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-Aug-15 | Market Option Sale (Planned) | 5,764 | $49.38 | $284,626.00 | (5%) 121.18K to 115.41K | 54% |
| 19-Aug-15 8:42 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Aug-15 | Option Exercise | 58,521 | -- | -- | 93% 62.66K to 121.18K | |
| 18-Feb-15 5:38 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-Feb-15 | Market Purchase | 11,000 | $18.00 | $198,000.00 | 21% 51.66K to 62.66K | 25% |